SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Barclays Maintains Labcorp at Equal-Weight, Raises Target to $380

Barclays maintained its Equal-Weight rating on Labcorp Holdings and raised its price target to $380 from $330.

LH
SquawkNews Desk 1 updates Updated Oct 29, 2026, 03:23 PM UTC

Story updates

03:23:45 PM UTC
SquawkNews
Labcorp Holdings Is Maintained at Equal-Weight by Barclays

Related stories

South Korea's Kospi Extends Losses, Down 5.3% at 5,622.84 M impact | EQUITY | Oct 30, 2026, 02:57 AM UTC Nikkei Falls 3% as Technology Shares Slide on AI Concerns The Nikkei fell 3% as technology shares declined amid concerns about artificial intelligence. M impact | EQUITY | Oct 30, 2026, 02:50 AM UTC Australian Gold Stocks Snap Four-Day Winning Streak as Bullion Slides Australian gold stocks ended a four-day winning streak as bullion prices fell amid bets on a Federal Reserve rate hike. M impact | EQUITY | Oct 30, 2026, 02:48 AM UTC Cyera Has Spoken to Investors About Raising Capital at $20 Billion Valuation Cyera has spoken to investors about a capital raise that would nearly double its valuation to $20 billion, The Information reports. M impact | EQUITY | Oct 30, 2026, 02:47 AM UTC AIA Shares Rise 3.98% to One-Month High AIA shares rose 3.98% intraday, their highest since Sept. 30. Goldman Sachs expects new business value growth to resume. M impact | EQUITY | Oct 30, 2026, 02:47 AM UTC Keytruda SC Quarterly Sales Reach a New Milestone Quarterly sales of Keytruda SC, which uses Alteogen’s technology, surpassed the stated threshold for the first time. M impact | EQUITY | Oct 30, 2026, 02:39 AM UTC